Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | November 28, 2024 |
| PDB ID | UniProt ID | Title ▲ | Descriptor |
|---|---|---|---|
| 1AVD | P02701 | THREE-DIMENSIONAL STRUCTURE OF THE TETRAGONAL CRYSTAL FORM OF EGG-WHITE AVIDIN IN ITS FUNCTIONAL COMPLEX WITH BIOTIN AT 2.7 ANGSTROMS RESOLUTION | AVIDIN COMPLEX WITH BIOTIN |
| 2AVI | P02701 | THREE-DIMENSIONAL STRUCTURES OF AVIDIN AND THE AVIDIN-BIOTIN COMPLEX | AVIDIN COMPLEX WITH BIOTIN |
| 1LOA | P04122 | THREE-DIMENSIONAL STRUCTURES OF COMPLEXES OF LATHYRUS OCHRUS ISOLECTIN I WITH GLUCOSE AND MANNOSE: FINE SPECIFICITY OF THE MONOSACCHARIDE-BINDING SITE | |
| 1LOA | P12306 | THREE-DIMENSIONAL STRUCTURES OF COMPLEXES OF LATHYRUS OCHRUS ISOLECTIN I WITH GLUCOSE AND MANNOSE: FINE SPECIFICITY OF THE MONOSACCHARIDE-BINDING SITE | |
| 1LOB | P04122 | THREE-DIMENSIONAL STRUCTURES OF COMPLEXES OF LATHYRUS OCHRUS ISOLECTIN I WITH GLUCOSE AND MANNOSE: FINE SPECIFICITY OF THE MONOSACCHARIDE-BINDING SITE | |
| 1LOB | P12306 | THREE-DIMENSIONAL STRUCTURES OF COMPLEXES OF LATHYRUS OCHRUS ISOLECTIN I WITH GLUCOSE AND MANNOSE: FINE SPECIFICITY OF THE MONOSACCHARIDE-BINDING SITE | |
| 1BA8 | P00734 | THROMBIN INHIBITOR WITH A RIGID TRIPEPTIDYL ALDEHYDES | |
| 1BA8 | 1BA8 | THROMBIN INHIBITOR WITH A RIGID TRIPEPTIDYL ALDEHYDES | |
| 1VIT | P00735 | THROMBIN:HIRUDIN 51-65 COMPLEX | |
| 1VIT | P28507 | THROMBIN:HIRUDIN 51-65 COMPLEX | |
| 7Z0Y | 7Z0Y | THSC20.HVTR04 Fab bound to SARS-CoV-2 Receptor Binding Domain | |
| 7Z0Y | P0DTC2 | THSC20.HVTR04 Fab bound to SARS-CoV-2 Receptor Binding Domain | |
| 7Z0X | 7Z0X | THSC20.HVTR26 Fab bound to SARS-CoV-2 Receptor Binding Domain | |
| 7Z0X | P0DTC2 | THSC20.HVTR26 Fab bound to SARS-CoV-2 Receptor Binding Domain | |
| 1NJX | P52026 | THYMINE-GUANINE MISMATCH AT THE POLYMERASE ACTIVE SITE | |
| 1NJY | P52026 | THYMINE-THYMINE MISMATCH AT THE POLYMERASE ACTIVE SITE | |
| 1TYX | P12528 | TITLE OF TAILSPIKE-PROTEIN | |
| 7YTP | B3Y653 | TLR7 in complex with an inhibitor | |
| 7YTP | 7YTP | TLR7 in complex with an inhibitor | |
| 7YTP | B3Y653 | TLR7 in complex with an inhibitor | |
| 7YTP | 7YTP | TLR7 in complex with an inhibitor | |
| 8F9K | Q9NUM4 | TMEM106B doublet filaments extracted from MSTD neurodegenerative human brain | |
| 7TMC | Q9NUM4 | TMEM106B singlet filament extracted from MSTD neurodegenerative human brain | |
| 7U18 | Q8N353 | TMEM106B(120-254) T185S protofilament from frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP) type A (all cases combined). | |
| 7U17 | Q9NUM4 | TMEM106B(120-254) T185S singlet amyloid fibril from frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP) type B case 2 (case 7). | |
| 7U16 | Q9NUM4 | TMEM106B(120-254) protofilament from frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP) type A (all cases combined). | |
| 7U11 | Q9NUM4 | TMEM106B(120-254) protofilament from frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP) type A (case 1) | |
| 7U10 | Q9NUM4 | TMEM106B(120-254) protofilament from progressive supranuclear palsy (PSP) case 2 | |
| 7U12 | Q9NUM4 | TMEM106B(120-254) singlet amyloid fibril from frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP) type A (case 2) | |
| 7U13 | Q9NUM4 | TMEM106B(120-254) singlet amyloid fibril from frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP) type A (case 4) | |
| 7U15 | Q9NUM4 | TMEM106B(120-254) singlet amyloid fibril from frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP) type B case 2 (case 7). | |
| 7U14 | Q9NUM4 | TMEM106B(120-254) singlet amyloid fibril from frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP) type C (case 8) | |
| 8SUN | Q6P9J9 | TMEM16F 1PBC | |
| 8SUR | Q6P9J9 | TMEM16F bound with Niclosamide | |
| 8TAG | Q6P9J9 | TMEM16F, with Calcium and PIP2, no inhibitor | |
| 8TAL | Q6P9J9 | TMEM16F, with Calcium and PIP2, no inhibitor, Cl1 | |
| 8TAI | Q6P9J9 | TMEM16F, with Calcium and PIP2, no inhibitor, Cl2 | |
| 8C6I | Q9UHN6 | TMEM2 ectodomain | |
| 8V1F | O15393 | TMPRSS2 complexed with the noncovalent inhibitor 6-amidino-2-napthol | |
| 1E3Q | P04058 | TORPEDO CALIFORNICA ACETYLCHOLINESTERASE COMPLEXED WITH BW284C51 | |
| 4TVK | P04058 | TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH A CHLOROTACRINE-JUGLONE HYBRID INHIBITOR | |
| 4W63 | P04058 | TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH A TACRINE-BENZOFURAN HYBRID INHIBITOR | |
| 4X3C | P04058 | TORPEDO CALIFORNICA ACETYLCHOLINESTERASE IN COMPLEX WITH A TACRINE-NICOTINAMIDE HYBRID INHIBITOR | |
| 1SOM | P04058 | TORPEDO CALIFORNICA ACETYLCHOLINESTERASE INHIBITED BY NERVE AGENT GD (SOMAN). | |
| 1FSG | Q26997 | TOXOPLASMA GONDII HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE COMPLEXED WITH 9-DEAZAGUANINE, ALPHA-D-5-PHOSPHORIBOSYL-1-PYROPHOSPHATE (PRPP) AND TWO MG2+ IONS | |
| 6VPJ | O14965 | TPX2 residues 7-20 fused to Aurora A residues 116-389 C247V + C319V double mutant dephosphorylated, and in complex with AMP-PNP | |
| 6VPJ | Q9ULW0 | TPX2 residues 7-20 fused to Aurora A residues 116-389 C247V + C319V double mutant dephosphorylated, and in complex with AMP-PNP | |
| 3X3F | O14763 | TRAIL-R2 Extracellular Region Complexed to a Fab fragment from Human Agonist Antibody KMTR2 | |
| 3X3F | 3X3F | TRAIL-R2 Extracellular Region Complexed to a Fab fragment from Human Agonist Antibody KMTR2 | |
| 4XXH | P36673 | TREHALOSE REPRESSOR FROM ESCHERICHIA COLI |
